Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Protests Mount Over CMS Proposal To Deny Virtual Colonoscopy Coverage

This article was originally published in The Gray Sheet

Executive Summary

Lawmakers, medical societies and patient advocacy groups joined the medtech industry last week in urging CMS to reverse its plan to deny coverage for computed tomography colonography to screen for colorectal cancer

You may also be interested in...



Medicare Denies Coverage Of CT Colonography For Cancer Screening

The hopes of imaging equipment and software makers, the American Cancer Society and radiologists were dashed with CMS' final decision not to cover computed tomography colonography for colorectal cancer screening

Medicare Denies Coverage Of CT Colonography For Cancer Screening

The hopes of imaging equipment and software makers, the American Cancer Society and radiologists were dashed with CMS' final decision not to cover computed tomography colonography for colorectal cancer screening

CMS Seeks Comments On Cost Effectiveness Of Virtual Colonoscopy

CMS says the evidence on health outcomes is not strong enough to support Medicare coverage of computed tomographic colonography as a screening tool for colorectal cancer, but is asking for more information on the procedure's cost effectiveness

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027216

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel